Edesa Biotech Research, Inc.
Registration:
8
of
11
(2022-11-01
to
2023-04-28)
Grant, Contribution or Other Financial Benefit
- Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.